McKesson (MCK) stock earns a BUY rating as it excels in tech-driven healthcare, specialty growth, and strong earnings ...

McKesson (MCK) is a 'Buy' with high-growth potential in healthcare services. Learn key risks and outlook for stock ...

Ammie McAsey, SVP of Supply Chain Operations, McKesson, explains the critical role of real-time visibility, digital tools, and cold chain innovation in ensuring product quality, reducing disruptions, ...

McKesson (NYSE: MCK) has outperformed the market over the past 10 years by 2.25% on an annualized basis producing an average annual return of 14.73%. Currently, McKesson has a market capitalization of ...

McKesson Corp on Tuesday said it and two other major U.S. drug distributors could be expected to pay up to $21 billion under a new proposal to resolve thousands of lawsuits alleging they helped fuel ...

The U.S. Supreme Court on Monday sided with Black Lives Matter activist DeRay McKesson in his ongoing effort to avoid a lawsuit filed by a police officer injured during a 2016 protest in Louisiana ...

In partnership with Bank of Texas, the Dallas Business Journal brought together leaders from fiscal and economic development ...

McKesson has an analyst consensus of Strong Buy, with a price target consensus of $835.08, an 11.32% upside from current levels. In a report released on September 30, Morgan Stanley also reiterated a ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

McKesson's fair value estimate has been raised from $793.21 to $829.57, driven by an improved outlook from analysts following ...

McKesson MCK is making a strategic shift that will redefine its role in the healthcare ecosystem. Long known as one of the ...

Oath Surgical has raised $24m to continue scaling a national network of surgery centres to support a lower-cost, more ...